Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Operating Cash Flow

Co-Diagnostics, Inc. (CODX) reported Operating Cash Flow of -$15.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13

  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.15M.
  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$7.85M.
  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.20M.
  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.90M.
  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$29.14M.
  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$29.16M.
  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$22.08M, a 436.17% decline from fiscal 2022.
  • Co-Diagnostics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $6.57M, a 84.01% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2026-06-30-$7.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$15.00M
10-Q · filed 2026-08-13
-$21.20M
derived: sum of 3 quarters · filed 2026-08-13
-$27.10M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$7.85M
10-Q · filed 2026-05-14
-$14.05M
derived: sum of 2 quarters · filed 2026-05-14
-$19.95M
derived: sum of 3 quarters · filed 2026-05-14
-$28.24M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$6.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$12.10M
derived: sum of 2 quarters · filed 2026-03-31
-$20.39M
derived: sum of 3 quarters · filed 2026-08-13
-$29.14M
10-K · filed 2026-03-31
2025-09-30-$5.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$14.19M
derived: sum of 2 quarters · filed 2026-08-13
-$22.94M
10-Q · filed 2025-11-13
-$31.17M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$8.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$17.03M
10-Q · filed 2026-08-13
-$25.26M
derived: sum of 3 quarters · filed 2026-08-13
-$32.49M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$8.75M
10-Q · filed 2026-05-14
-$16.98M
derived: sum of 2 quarters · filed 2026-05-14
-$24.21M
derived: sum of 3 quarters · filed 2026-05-14
-$29.41M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$8.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
-$15.46M
derived: sum of 2 quarters · filed 2026-03-31
-$20.66M
derived: sum of 3 quarters · filed 2026-03-31
-$29.16M
10-K · filed 2026-03-31
2024-09-30-$7.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$12.43M
derived: sum of 2 quarters · filed 2025-11-13
-$20.92M
10-Q · filed 2025-11-13
-$25.70M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$5.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$13.69M
10-Q · filed 2025-08-14
-$18.47M
derived: sum of 3 quarters · filed 2025-08-14
-$24.24M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$8.49M
10-Q · filed 2025-05-08
-$13.27M
derived: sum of 2 quarters · filed 2025-05-08
-$19.03M
derived: sum of 3 quarters · filed 2025-05-08
-$24.65M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31-$4.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$10.54M
derived: sum of 2 quarters · filed 2025-03-27
-$16.16M
derived: sum of 3 quarters · filed 2025-03-27
-$22.08M
10-K · filed 2025-03-27
2023-09-30-$5.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$11.39M
derived: sum of 2 quarters · filed 2024-11-07
-$17.30M
10-Q · filed 2024-11-07
-$21.31M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30-$5.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$11.54M
10-Q · filed 2024-08-08
-$10.71M
10-Q · filed 2023-08-10
-$15.55M
derived: sum of 3 quarters · filed 2024-08-08
-$14.43M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$5.92M
10-Q · filed 2024-05-09
-$5.50M
10-Q · filed 2023-05-11
-$9.93M
derived: sum of 2 quarters · filed 2024-05-09
-$8.81M
derived: sum of 3 quarters · filed 2024-05-09
-$7.15M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$4.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$2.89M
derived: sum of 2 quarters · filed 2024-03-14
-$1.24M
derived: sum of 3 quarters · filed 2024-03-14
$6.57M
10-K · filed 2024-03-14
2022-09-30$1.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$2.77M
derived: sum of 2 quarters · filed 2023-11-09
$10.58M
10-Q · filed 2023-11-09
$15.46M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$9.46M
10-Q · filed 2023-08-10
$14.34M
derived: sum of 3 quarters · filed 2023-08-10
$25.85M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$7.81M
10-Q · filed 2023-05-11
$12.68M
derived: sum of 2 quarters · filed 2023-05-11
$24.19M
derived: sum of 3 quarters · filed 2023-05-11
$36.62M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$4.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$16.39M
derived: sum of 2 quarters · filed 2023-03-16
$28.81M
derived: sum of 3 quarters · filed 2023-03-16
$41.08M
10-K · filed 2023-03-16
2021-09-30$11.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$23.93M
derived: sum of 2 quarters · filed 2022-11-10
$36.20M
10-Q · filed 2022-11-10
$56.16M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$12.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$24.69M
10-Q · filed 2022-08-11
$44.65M
derived: sum of 3 quarters · filed 2022-08-11
$53.21M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$12.27M
10-Q · filed 2022-05-12
$32.23M
derived: sum of 2 quarters · filed 2022-05-12
$40.78M
derived: sum of 3 quarters · filed 2022-05-12
$41.77M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$19.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
$28.51M
derived: sum of 2 quarters · filed 2022-03-24
$29.50M
derived: sum of 3 quarters · filed 2022-03-24
$28.17M
10-K · filed 2022-03-24
2020-09-30$8.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$9.54M
derived: sum of 2 quarters · filed 2021-11-12
$8.21M
10-Q · filed 2021-11-12
$6.60M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$987.07K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$348.46K
10-Q · filed 2021-08-12
-$1.96M
derived: sum of 3 quarters · filed 2021-08-12
-$3.18M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$1.34M
10-Q · filed 2021-05-13
-$2.95M
derived: sum of 2 quarters · filed 2021-05-13
-$4.16M
derived: sum of 3 quarters · filed 2021-05-13
-$5.49M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$1.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$2.83M
derived: sum of 2 quarters · filed 2021-03-25
-$4.16M
derived: sum of 3 quarters · filed 2021-03-25
-$5.53M
10-K · filed 2021-03-25
2019-09-30-$1.22M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16
-$2.54M
derived: sum of 2 quarters · filed 2020-11-16
-$3.91M
10-Q · filed 2020-11-16
-$4.87M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30-$1.33M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03
-$2.70M
10-Q/A · filed 2020-11-03
-$3.66M
derived: sum of 3 quarters · filed 2020-11-03
-$4.84M
derived: sum of 4 quarters · filed 2020-11-03
2019-03-31-$1.37M
10-Q · filed 2020-05-14
-$2.33M
derived: sum of 2 quarters · filed 2020-05-14
-$3.51M
derived: sum of 3 quarters · filed 2020-05-14
-$4.48M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$960.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$2.14M
derived: sum of 2 quarters · filed 2020-03-30
-$3.11M
derived: sum of 3 quarters · filed 2020-03-30
-$4.08M
10-K · filed 2020-03-30
2018-09-30-$1.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$2.15M
derived: sum of 2 quarters · filed 2019-11-12
-$3.12M
10-Q · filed 2019-11-12
-$4.11M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$967.97K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$1.94M
10-Q · filed 2019-08-14
-$2.93M
derived: sum of 3 quarters · filed 2019-08-14
-$4.48M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$968.52K
10-Q · filed 2019-05-14
-$1.96M
derived: sum of 2 quarters · filed 2019-05-14
-$3.51M
derived: sum of 3 quarters · filed 2019-05-14
-$3.76M
derived: sum of 4 quarters · filed 2019-05-14
2017-12-31-$992.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$2.54M
derived: sum of 2 quarters · filed 2019-04-01
-$2.79M
derived: sum of 3 quarters · filed 2019-04-01
-$3.21M
10-K · filed 2019-04-01
2017-09-30-$1.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
-$1.80M
derived: sum of 2 quarters · filed 2018-11-14
-$2.22M
10-Q · filed 2018-11-14
-$2.77M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$247.87K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
-$667.60K
10-Q · filed 2018-08-10
-$667.30K
10-Q · filed 2017-08-25
-$1.22M
derived: sum of 3 quarters · filed 2018-08-10
-$1.52M
derived: sum of 4 quarters · filed 2018-08-10
2017-03-31-$419.74K
10-Q · filed 2018-05-14
-$975.63K
derived: sum of 2 quarters · filed 2018-05-14
-$1.27M
derived: sum of 3 quarters · filed 2018-05-14
2016-12-31-$555.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28
-$853.95K
derived: sum of 2 quarters · filed 2018-03-28
-$1.31M
10-K · filed 2018-03-28
2016-09-30-$298.06K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
-$756.37K
10-Q · filed 2017-11-14
2016-06-30-$458.32K
10-Q · filed 2017-08-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01